Dr. Constantinos-Kurt Wibmer

Constantinos-Kurt Wibmer is an immunologist and virologist recognized for contributions to the understanding of antibody responses to emerging viral pathogens. His work has been closely associated with leading South African research initiatives on HIV and SARS-CoV-2, particularly in the context of variant evolution, immune escape, and vaccine performance. He has collaborated extensively in multidisciplinary teams addressing urgent global health challenges.

Wibmer’s research centers on viral immunology, with a strong emphasis on neutralizing antibody responses, monoclonal antibody discovery, and mechanisms of immune evasion. His publications in leading journals detail the characterization of major SARS-CoV-2 variants, including Beta and Omicron, and their impact on vaccine-elicited immunity. He has also contributed to studies on HIV vaccine strategies and antibody-mediated protection, reflecting sustained expertise in adaptive immunity and translational vaccine science.

Notable contributions include early identification and phenotypic analysis of variants of concern, evaluation of vaccine efficacy against immune-evasive strains, and development of antibody-based therapeutic approaches. His work on genomic surveillance and global disparities highlights a commitment to equitable pandemic preparedness. Collectively, his scholarship bridges fundamental immunology and real-world public health response.